Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.24.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Unit Activity
A summary of our restricted stock unit activity is set forth below:

Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2022 59,215  $ 77.87 
Granted 208,960  $ 25.04 
Released (119,995) $ 44.83 
Forfeited (51,372) $ 39.40 
Outstanding as of December 31, 2023 96,808  $ 25.21 
Schedule of Stock Options Activity
A summary of our stock option activity under the 2018 Plan and related information is as follows:
Number of Shares Weighted Average
Exercise Price		 Weighted Average
Remaining
Contractual Term
(years)		 Aggregate Intrinsic
Value
Outstanding as of December 31, 2022 1,750  $ 71.73  5.60 $ — 
Granted 1,500  38.15 
Exercised —  — 
Forfeited (750) 54.00 
Outstanding as of December 31, 2023 2,500  $ 56.89  4.19 $ — 
Exercisable as of December 31, 2023 2,500  $ 56.89  4.19 $ — 
A summary of our stock option activity under the 2009 Plan and related information is set forth below:

Number of Shares Weighted Average Exercise Price
Weighted Average Remaining
Contractual Term (years)
 Aggregate Intrinsic Value
Outstanding as of December 31, 2022 17,495  $ 40.22  4.22 $ 130 
Granted —  — 
Exercised (1,895) 30.36 
Cancelled/Expired (975) 67.56 
Outstanding as of December 31, 2023 14,625  $ 39.67  2.94 $ — 
Exercisable as of December 31, 2023 14,625  $ 39.67  2.94 $ — 
Schedule of Stock-Based Compensation
Compensation cost that has been included in our consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Year Ended December 31,
Stock-based compensation 2023 2022
Cost of revenues $ 447  $ 210 
Sales and marketing 135  104 
General and administrative 3,294  2,542 
Research and development 195  153 
Total stock-based compensation $ 4,071  $ 3,009